15-keto-13-14-dihydroprostaglandin-f2alpha has been researched along with Toxoplasmosis--Animal* in 5 studies
5 other study(ies) available for 15-keto-13-14-dihydroprostaglandin-f2alpha and Toxoplasmosis--Animal
Article | Year |
---|---|
Effect of fungal alkaloids on the development of pregnancy and endocrine foetal-placental function in the goat.
The response to Claviceps purpurea sclerotia administration in pregnant goats was examined in terms of changes in the levels of plasma hormones, the development of pregnancy and kid production. Six treated goats were each given 15 mg milled sclerotia (i.e. 0.105 mg ergotamine) per kilogram live weight twice daily via a stomach tube from days 98 +/- 2 to 107 +/- 2 of gestation. Seven control goats were given water twice daily via a stomach tube during the same period of gestation. The goats were observed for clinical signs of disease, rectal temperatures and live weights were recorded and the condition of the foetuses was monitored by real-time ultrasonography. All control goats delivered live kids. In the treated group two goats aborted 33 and 47 days, respectively, after the start of the administration period, two goats each delivered one normal and one weak kid, and the two remaining goats delivered apparently normal kids. All six treated goats became depressed and had poor appetite during the period of sclerotia administration. Rectal temperatures were significantly increased and live weight changes significantly decreased in the animals in the treated group compared to the control group during the period of C. purpurea administration. Ultrasound examination revealed that foetal deaths occurred between 1 and 42 days before abortion or birth. The appearance of the aborted foetuses varied from fresh to mummified, depending on the number of days between foetal death and expulsion. Microbiological and serological investigations revealed no infectious causes of reproductive failure. The level of 15-ketodihydro-PGF2 alpha was high in goats that aborted following administration of C. purpurea compared with the level in control goats. The oestrone sulphate level did not increase before abortion in the treated goats as in the controls before parturition. There were also changes in these hormones in the four treated goats that delivered live kids, but the changes were considerably smaller. These findings indicate that the endocrine foetal-placental function was disturbed, probably due to injury caused by the C. purpurea toxin ergotamine in the placenta and foetus. Topics: Abortion, Veterinary; Adrenergic alpha-Agonists; Animals; Body Weight; Claviceps; Dinoprost; Endocrine Glands; Enzyme-Linked Immunosorbent Assay; Ergotamine; Estrone; Female; Fetal Death; Goats; Heart Rate, Fetal; Placenta; Pregnancy; Pregnancy Outcome; Progesterone; Toxoplasma; Toxoplasmosis, Animal | 1998 |
Effect of Toxoplasma gondii infection on the development of pregnancy and on endocrine foetal-placental function in the goat.
The effect of Toxoplasma gondii inoculation on pregnancy and on endocrine foetal-placental function in pregnant goats was studied. Five susceptible goats were inoculated subcutaneously with T. gondii bradyzoites at 71 +/- 2 days of gestation. Another five goats were used as controls. Plasma was analysed for progesterone, oestrone sulphate and 15-ketodihydro-PGF2 alpha. The condition of the foetuses was monitored by real-time ultrasonography. All inoculated goats aborted or delivered stillborn or weak kids 54-73 days after inoculation. None of the goats showed signs of general disease. In cases of foetal death, the ultrasound examination revealed that death occurred between day 1 and 12 before abortion or birth. The appearance of the foetuses varied from fresh to mummified, depending on the number of days between foetal death and expulsion. All five goats became serologically positive to T. gondii after inoculation. None of the goats used as controls aborted, but one goat delivered one mummified and one weak kid for unknown reasons. In inoculated animals an increase in 15-ketodihydro-PGF2 alpha levels in plasma and a subsequent tendency to a decrease in oestrone sulphate levels were observed from about day 40 after inoculation and until abortion or birth. High levels of 15-ketodihydro-PGF2 alpha were seen after foetal death. High levels of 15-ketodihydro-PGF2 alpha were not always followed by a drop in progesterone levels. The mean level of progesterone was slightly decreased after inoculation and onwards. The pattern of progesterone levels around abortion in the inoculated goats was very similar to the pattern around parturition in the control goats. However, 15-ketodihydro-PGF2 alpha levels were higher both before and after abortion in inoculated goats than in control goats. The level of oestrone sulphate did not increase in the inoculated group before abortion in contrast to the level in goats which delivered healthy kids. The patterns of changes in levels of 15-ketodihydro-PGF2 alpha and oestrone sulphate in inoculated animals indicate that the endocrine foetal-placental function was disturbed in most of the inoculated goats, probably due to the injury caused by the establishment and development of T. gondii infection in the placenta and foetus. Topics: Abortion, Veterinary; Animals; Dinoprost; Estrogens, Conjugated (USP); Estrone; Female; Goat Diseases; Goats; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Parasitic; Progesterone; Time Factors; Toxoplasma; Toxoplasmosis, Animal | 1996 |
The effect of Toxoplasma gondii infection in flunixin meglumine treated pregnant ewes as monitored by plasma levels of 15-ketodihydroprostaglandin F2 alpha, progesterone, oestrone sulphate and ultrasound scanning.
The aim of this study was to examine the endocrinological response (15-ketodihydro-PGF2 alpha, progesterone and oestrone sulphate) of pregnant ewes which were constantly treated with flunixin meglumine (FM) after infection with Toxoplasma gondii. Seven Swedish Peltsheep ewes were dosed orally with 2,000 T. gondii oocysts at 90.5 (82-94) days of pregnancy. The ewes were treated with FM, 1 mg/kg, intramuscularly twice a day, starting one day before infection until the end of the gestation period. Further three ewes were treated with FM alone during the corresponding time of pregnancy. Another four ewes were used as uninfected and untreated controls. All infected ewes developed antibodies to T. gondii and aborted, but the FM treated control group and the non-treated control group, which remained seronegative, delivered the lambs in the normal gestation range. No early abortions (less than 10 days after infection) were seen in the infected group. The endocrinological changes reflected the pathological changes in the uterus and foetuses. FM could neither completely inhibit prostaglandin release during abortion nor the physiological change of the hormone before parturition even though it depressed prostaglandin release before abortion or parturition and eliminated fever. The infectious process caused by the organism was probably not affected. FM treatment alone had no observed negative effects on pregnant ewes and their foetuses. Topics: Animals; Clonixin; Dinoprost; Estrone; Female; Nicotinic Acids; Pregnancy; Progesterone; Sheep; Sheep Diseases; Toxoplasmosis, Animal; Ultrasonography | 1990 |
The effect of Toxoplasma gondii infection in unvaccinated and iscom-vaccinated pregnant ewes as monitored by plasma levels of 15-ketodihydroprostaglandin F2 alpha, progesterone, and oestrone sulphate.
In order to study the effect of Toxoplasma infection on hormonal levels in pregnant ewes, twenty-eight Scottish Blackface ewes were dosed orally with Toxoplasma gondii oocytes at 91 +/- 1 days of gestation. Fifteen of these ewes were vaccinated with an experimental Toxoplasma iscom vaccine prior to inoculation. Further three ewes were used as non-infected controls. All challenged ewes became infected. Plasma was analysed for the content of 15-ketodihydro-PGF2 alpha, progesterone and oestrone sulphate. The endocrinological changes appeared to reflect the pathological changes in the uterus. Infected animals tended to show an increase in the levels of the prostaglandin metabolite between two and eleven days after challenge, followed by a decrease in progesterone and later also of oestrone sulphate levels. Following the initial phase, the pattern was more variable but related to the outcome of gestation. There was a marked tendency towards more normal endocrinological patterns in the vaccinated animals in comparison to unvaccinated challenged ones. Topics: Adjuvants, Immunologic; Animals; Dinoprost; Estrone; Female; Pregnancy; Pregnancy Complications, Infectious; Progesterone; Sheep; Sheep Diseases; Toxoplasmosis, Animal; Vaccination | 1990 |
Levels of 15-ketodihydroprostaglandin F2 alpha during experimental Toxoplasma gondii infection in non-pregnant ewe lambs.
In order to study the relation between prostaglandin F2 alpha levels and fever during Toxoplasma gondii infection, six non-pregnant ewe lambs were exposed orally to T. gondii oocysts and an additional four animals were used as non-inoculated controls. Rectal temperature was measured daily during four weeks and plasma samples were analysed for the content of 15-ketodihydroprostaglandin F2 alpha. As compared to controls, the inoculated animals had significantly elevated rectal temperatures on days 4-16 after infection, but no concomitant changes in prostaglandin F2 alpha metabolite levels were recorded. Topics: Animals; Body Temperature; Dinoprost; Female; Sheep; Sheep Diseases; Toxoplasmosis, Animal | 1990 |